SEC Contract Filing

Filing Date: 2025-04-29

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101employmentagreem.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i13c89e30e27d48e3b27b9aec06920515_1"></div><div style="min-height:31.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:3.95pt;padding-right:11.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Execution Version</font></div><div style="margin-top:8.4pt"><font><br></font></div><div style="padding-left:213.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EMPLOYMENT AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:59.95pt;padding-right:11.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This EMPLOYMENT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of August 10, 2022 by and between NeoGenomics, Inc. (t</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">he &#8220;Comp</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any&#8221;) and Alicia Olivo (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">the &#8220;Execu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">tive&#8221;).</font></div><div><font><br></font></div><div style="padding-left:60pt;padding-right:11.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Executive and the Company entered into a certain letter agreement dated May 11, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Previous Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) memorializing the terms and conditions of the Executive&#8217;s role as Interim General Counsel of the Company, effective as of April 25, 2022&#59;</font></div><div><font><br></font></div><div style="padding-left:60pt;padding-right:11.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Executive possesses certain experience and expertise that qualifies him or her to provide the direction and leadership required by the Company&#59; and</font></div><div><font><br></font></div><div style="padding-left:59.95pt;padding-right:11.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to continue to employ the Executive and to employ the Executive as General Counsel and Corporate Secretary of the Company and the Executive wishes to accept such continued employment and new role&#59;</font></div><div style="margin-top:13.7pt;padding-left:60pt;padding-right:11.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:131.95pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:26.95pt">Position and Duties.</font></div><div><font><br></font></div><div style="padding-left:60pt;padding-right:11.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:34.7pt">Effective as of the date hereof, the Executive will continue to be employed by the Company and NeoGenomics Laboratories, Inc., its primary operating subsidiary, on a full-time basis, and will serve the Company and NeoGenomics Laboratories, Inc. as its General Counsel and Corporate Secretary or such other position or positions as the Company may determine in the future. The Executive will report to and be subject to the general supervision and direction of the Company&#8217;s Chief Executive Officer. In addition, the Executive may be asked from time to time to serve in similar capacities for one or more of the Company&#8217;s Affiliates or as a director or officer of one or more of the Company&#8217;s Affiliates, each without further compensation. For purposes of this Agreement, &#8220;</font><font style="color:#00000